BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25946975)

  • 21. ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis.
    Compagnone M; Gatti V; Presutti D; Ruberti G; Fierro C; Markert EK; Vousden KH; Zhou H; Mauriello A; Anemone L; Bongiorno-Borbone L; Melino G; Peschiaroli A
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13254-13259. PubMed ID: 29162693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.
    Bennett KL; Karpenko M; Lin MT; Claus R; Arab K; Dyckhoff G; Plinkert P; Herpel E; Smiraglia D; Plass C
    Cancer Res; 2008 Jun; 68(12):4494-9. PubMed ID: 18559491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
    Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
    Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
    Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
    Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
    PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas.
    Wang H; Zhang G; Wu Z; Lu B; Yuan D; Li X; Lu Z
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C216-21. PubMed ID: 26506880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of CD147 expression promotes chemosensitivity in HNSCC cells by deactivating MAPK/ERK signaling pathway.
    Ma C; Wang J; Fan L; Guo Y
    Exp Mol Pathol; 2017 Feb; 102(1):59-64. PubMed ID: 28062212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
    Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
    Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
    de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
    Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of RAD17 in head and neck cancer.
    Zhao M; Begum S; Ha PK; Westra W; Califano J
    Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
    Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Junctional Adhesion Molecule-A in Head and Neck Squamous Cell Carcinoma.
    Kurose M; Kakuki T; Takano K; Kondo A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Kojima T; Himi T
    Adv Otorhinolaryngol; 2016; 77():92-7. PubMed ID: 27115511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks.
    Michna A; Schötz U; Selmansberger M; Zitzelsberger H; Lauber K; Unger K; Hess J
    Radiat Oncol; 2016 Jul; 11():94. PubMed ID: 27455841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer.
    Hsu DS; Lan HY; Huang CH; Tai SK; Chang SY; Tsai TL; Chang CC; Tzeng CH; Wu KJ; Kao JY; Yang MH
    Clin Cancer Res; 2010 Sep; 16(18):4561-71. PubMed ID: 20823140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma.
    Miyamoto C; Maehata Y; Motohashi K; Ozawa S; Ikoma T; Hidaka K; Wada-Takahashi S; Takahashi SS; Yoshino F; Yoshida A; Kubota E; Hata R; Lee MC
    Biomed Res; 2014; 35(6):381-8. PubMed ID: 25743344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma.
    Jin Y; Yang Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31324732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.